Literature DB >> 12747554

Regulation of mRNA production by the adenoviral E1B 55-kDa and E4 Orf6 proteins.

S J Flint1, R A Gonzalez.   

Abstract

The E1B 55-kDa and E4 Orf6 proteins of human subgroup C adenoviruses both counter host cell defenses mediated by the cellular p53 protein and regulate viral late gene expression. A complex containing the two proteins has been implicated in induction of selective export of viral late mRNAs from the nucleus to the cytoplasm, with concomitant inhibition of export of the majority of newly synthesized cellular mRNAs. The molecular mechanisms by which these viral proteins subvert cellular pathways of nuclear export are not yet clear. Here, we review recent efforts to identify molecular and biochemical functions of the E1B 55-kDa and E4 Orf6 proteins required for regulation of mRNA export, the several difficulties and discrepancies that have been encountered in studies of these viral proteins, and evidence indicating that the reorganization of the infected cell nucleus and production of viral late mRNA at specific intra-nuclear sites are important determinants of selective mRNA export in infected cells. In our view, it is not yet possible to propose a coherent molecular model for regulation of mRNA export by the E1B 55-kDa and E4 Orf6 proteins. However, it should now be possible to address specific questions about the roles of potentially relevant properties of these viral proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12747554     DOI: 10.1007/978-3-662-05597-7_10

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  37 in total

1.  Viral regulation of mRNA export.

Authors:  Rozanne M Sandri-Goldin
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

2.  CRM1-dependent transport supports cytoplasmic accumulation of adenoviral early transcripts.

Authors:  Melanie Schmid; Ramon A Gonzalez; Thomas Dobner
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

3.  Timely synthesis of the adenovirus type 5 E1B 55-kilodalton protein is required for efficient genome replication in normal human cells.

Authors:  Jasdave S Chahal; S J Flint
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

4.  Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells.

Authors:  Sabrina Schreiner; Peter Wimmer; Hüseyin Sirma; Roger D Everett; Paola Blanchette; Peter Groitl; Thomas Dobner
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

5.  Both BC-box motifs of adenovirus protein E4orf6 are required to efficiently assemble an E3 ligase complex that degrades p53.

Authors:  Paola Blanchette; Chi Ying Cheng; Qin Yan; Gary Ketner; David A Ornelles; Thomas Dobner; Ronald C Conaway; Joan Weliky Conaway; Philip E Branton
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

6.  Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export.

Authors:  Jennifer L Woo; Arnold J Berk
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

7.  Adenovirus E1B 55-kilodalton protein is required for both regulation of mRNA export and efficient entry into the late phase of infection in normal human fibroblasts.

Authors:  Ramon Gonzalez; Wenying Huang; Renee Finnen; Courtney Bragg; S J Flint
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

8.  Intranuclear targeting and nuclear export of the adenovirus E1B-55K protein are regulated by SUMO1 conjugation.

Authors:  Kathrin Kindsmüller; Peter Groitl; Barbara Härtl; Paola Blanchette; Joachim Hauber; Thomas Dobner
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-11       Impact factor: 11.205

Review 9.  Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation.

Authors:  Andrew N Blackford; Roger J A Grand
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

10.  Protein arginine methylation during lytic adenovirus infection.

Authors:  Julia Kzhyshkowska; Elisabeth Kremmer; Markus Hofmann; Hans Wolf; Thomas Dobner
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.